Baidu
map

Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa

Delgado-Valverde, M; Portillo-Calderón, I; Alcalde-Rico, M; Conejo, MC; Hidalgo, C; Esperón, CD; Pascual, A

Delgado-Valverde, M (通讯作者),Univ Seville, Hosp Univ Virgen Macarena, UGC Enfermedades Infecciosas & Microbiol Clin, CSIC,Inst Biomed Sevilla IBIS, Seville, Spain.;Delgado-Valverde, M (通讯作者),Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Seville, Spain.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023; ():

Abstract

Purpose Relebactam is a novel beta-lactamase inhibitor, which, when combined with imipenem/cilastatin, is active against both class A and class C beta......

Full Text Link


Baidu
map
Baidu
map
Baidu
map